Pier 70 Ventures - aVenture Asset Manager Research
Location
Seattle, WA, US
Founded
2017
Pier 70 Ventures focuses on impact-driven innovation, primarily investing in disruptive healthcare technologies. The firm targets early-stage companies, typically participating in Seed to Series B rounds. Their investment strategy emphasizes finding and funding entrepreneurs who are pushing the boundaries of innovation in the healthcare sector.
Notable portfolio companies include DocSpera, KayoThera, Vital View Technologies, and ZeroCarb. Pier 70 Ventures offers more than just capital, providing mentorship and access to their global network. They prioritize building diverse teams and aim to empower bright, enthusiastic leaders. The firm's approach, which they call "Venture Boldly," focuses on accelerating high-growth sustainable companies and creating collective value through their investments.
Pier 70 Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count4
Top Investment Stages
Seed2 (50.0%)
Series A1 (25.0%)
Series B1 (25.0%)
Stage Mix
Seed 50%Series A 25%Series B 25%
Concentration shown as share of disclosed investments by stage.
